Filters
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/66723b77cced45771fc02370_Banana%20Plant.jpeg)
Biotech
The Biotech Startup Using Artificial Intelligence For Naturally Derived Drugs
Artificial intelligence powered drug discovery startup Enveda has raised $55 million in a Series B financing round.
June 18, 2024
Biotech
Artificial Intelligence
Startups
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/66439bf8c8064f2b1b746595_Bioreactor%20Caladan.jpeg)
Biotech
Next Generation Bioreactors Are Coming To Change Synthetic Biology
Caladan Bio is developing next generation bioreactors that are capable of enhancing data capture and improving experimentation for synthetic biology companies.
May 14, 2024
Biotech
Startups
Venture Capital
Cellular Agriculture
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/663e632538428922580f130d_Floor%20scale.jpeg)
Biotech
Novo Nordisk Is All In On Weight Loss Drugs
Novo Nordisk (NASDAQ:NVO) has announced a new $600 million collaboration with Metaphore Biotechnologies to develop two new weight loss drug candidates.
May 10, 2024
Public Companies
Biotech
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/65ddf4e1f777b7bfa5857111_Stem%20Cell.jpeg)
Biotech
The Startup Bringing Stem Cells Together With Artificial Intelligence
CellVoyant is leveraging artificial intelligence and computer vision to develop new stem cell based therapeutics for chronic diseases.
February 24, 2024
Biotech
Venture Capital
Startups
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/65d019603df4b2551194cb5b_Scale.jpeg)
Biotech
BioAge Labs Is Working On A New Drug For Weight Loss
BioAge Labs is developing a new type of weight loss drug that mimics the behaviour of a molecule that is typically naturally stimulated through exercise.
February 14, 2024
Biotech
Seed Round
Startups
Venture Capital
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/65c1324dae85ebaf7d0c5770_Dog2.jpeg)
Biotech
Loyal Doses Their First Dog In Groundbreaking Canine Longevity Clinical Trial
Biotechnology company Loyal has announced they have dosed their first ever dog in their clinical trial which aims to increase lifespan of older animals.
February 4, 2024
Biotech
General
Startups
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/65bd26c42b1a52409dccd513_Cash%20on%20Scale.jpeg)
Biotech
The Big Biotech Bets On New Obesity Treatments
Wall Street and Silicon Valley have recently been making big new bets on potential breakthrough ways to treat obesity through novel therapeutics.
February 2, 2024
Biotech
Venture Capital
Startups
Public Companies
![](https://cdn.prod.website-files.com/64c2a9ec9c767dc6142b968b/65a5469601de246d91ec7b33_Alto%20Neuroscience.jpeg)
Biotech
Alto Neuroscience Wants To Be The Next Big Biotech IPO
Los Altos, California based biotech company Alto Neuroscience has officially filed with the SEC to raise $100M USD in an IPO on the New York Stock Exchange.
January 15, 2024
IPO
Public Companies
Biotech